These pro-tumor activities could mediate the unfavorable prognostic effect of ASPH overexpression in renal, cervical, pancreatic, lung and thyroid cancer (protein atlas database: https://www.proteinatlas.org/ENSG00000198363-ASPH). The gene discussed is ASPH; the disease is thyroid gland carcinoma.